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Percutaneous Sacroplasty for Sacral
Metastatic Tumors Under Fluoroscopic
Guidance Only
Percutaneous sacroplasty is a safe and effective procedure for sacral insuffi-
cient fractures under CT or fluoroscopic guidance; although, few reports exist
about sacral metastatic tumors. We designed a pilot study to treat intractable pain
caused by a sacral metastatic tumor with sacroplasty. A 62-year-old man and a
38-year-old woman with medically intractable pain due to metastatic tumors of S1
from lymphoma and lung cancer, respectively, underwent percutaneous
sacroplasty. Over the course of the follow-up period, the two patients experi-
enced substantial and immediate pain relief that persisted over a 3-month and
beyond. The woman had deposition of PMMA (polymethyl methacrylate) in the
needle track, but did not experience significant symptoms. No other peri-proce-
dural complications were observed for either patient.
acroplasty is a safe and effective procedure in the treatment of sacral
insufficient fractures under CT or fluoroscopic guidance (1, 2). Like
vertebroplasty, it can also be used for skeletal metastatic tumors;
however, few reports are described the literature (1, 3). Here, we report two cases
with a description of the percutaneous sacroplasty method using bone cement
injections for sacral metastatic tumors, under fluoroscopic guidance only.
CASE REPORTS
Case 1
A 62-year-old man affected by lymphoma with known skeletal metastases, was
referred to our department with symptoms of refractory pain after non-operative
therapy, which included chemotherapy, local radiotherapy, and opioid treatment. A
month prior to the referral, the patient was admitted for a vertebroplasty for the T12,
L1, L2 and L3 due to severe low back pain. The operation was significantly relieved
from pain; however, the lower back pain progressively returned over the course of a
month. Lumbosacral magnetic resonance imaging (MRI) and CT examinations (Fig.
1A, B) revealed an S1 mixed lesion. The patient had no weakness or neurosensory
deficit.
After conferral with the orthopedic surgeon, discussion with the patient’s family, and
consent from the patient, percutaneous sacroplasty treatment was decided upon to
restore sacrum stability and resolve the pain caused by the mixed lesion.
Prophylactic antibiotic therapy was performed by intravenous administration of 2 g
of Cefuroxime Sodium (Livzon Medical Ltd, China), 30 minutes before commencing
the procedure and was continued for 3 day after the procedure.
Before the procedure, a careful review of the radiology films and a measure of skin
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Fig. 1. 62-year-old man with metastasis at T12, L1, L2, L3, and S1 level from lymphoma.
A, B. Sagittal CT (A) shows mixed sclerotic and poorly marinated low attenuation lesion in
S1. Sagittal T2-weighted with fat saturated MR image (B) shows high band-like signal at
periphery and iso-to-low signal in central portion of lesion.
C. Transaxial schematic drawing demonstrates that trans-sacroiliac joint approach and
positioning of 13-gauge bevel-edge needle is recommended for sacroplasties. Needle
courses ilium, sacroiliac joint and sacral pedicle to center of lesion. Rotating needle to aim
bevel-edge needle toward nerve root is recommended to avoid injury.
D, E. Lateral (D) and anteroposterior (E) fluoroscopic versions reveal location of needle tip
in lesion.
F, G. Lateral (F) and anteroposterior (G) post-operative fluoroscopic views show equal
distribution of cement with no cement migration and leakage at T12, L1, L2, L3, and S1. 
Gdepth to the center of the lesion as well as the S1 marrow
space from the dorsal to ventral cortex, were performed as
specified by the trans-sacroiliac joint approach (Fig. 1C).
The patient was placed in the prone position, comfortable
and relaxed. Next, the lumbo-sacral region was prepped
and draped to ensure sterility. The procedure was
performed under local anesthesia. The sterile draped
fluoroscope was positioned at the anteroposterior (AP)
view. The lumbo-sacral junction was centered and the C-
arm adjusted until the S1 foramen could be visualized. A
small dermatotomy incision was made with a scalpel blade.
Next, a 13-gauge bevel-edge needle (OptiMED
Medizinische Instrumente GmbH, Germany) was
introduced through the skin incision and subcutaneous
tissue, to the periosteum of the bone, and then advanced to
the center of the mixed lesion at the center of S1
transverse ilium, sacroiliac joint and sacrum (Fig. 1D, E)
with the aid of a mallet. We adjusted the cephalopod and
left-right angle according to the sagittal and axial films of
CT and MRI until the needle attained the lesion under all
fluoroscopy projections. After removal the inner needle, a
commercial polymethyl methacrylate (PMMA) (Simplex P,
Stryker Howmedica Osteonics, East Rutherford, NJ) was
carefully injected carefully into the lesion under continuous
fluoroscopic guidance in the lateral and AP projections
(Fig. 1F, G) to ensure the adequate filling of the lesion and
avoidance of PMMA leakage. A total of 6 ml of PMMA
was injected. The post-procedural fluoroscopic findings
showed optimal filling of the lesion with no evidence of
PMMA extravasation.
The patient experienced significant pain relief the next
day and was able to ambulate without assistance. The
patient was discharged three days after the sacroplasty,
following the completion of the prophylactic antibiotic
therapy. Short-term (within 2 weeks) and middle-term
(within 3 months) clinical follow-up were assessed by
telephone. The physical examination elicited no pain upon
palpation of the lumbosacral spine. 
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Fig. 2. 38-year-old woman with metasta-
tic tumor at S1, originating from lung
cancer.
A, B. Sagittal T2-weighted with fat
saturated MR imaging (A) shows
abnormal signal at S1. Axial CT scan
(B) demonstrates osteolytic change of
S1, which is characterized by
breakdown of peri-cortex of S1 and S1
foramen.
C, D. Anteroposterior (C) and lateral (D)
views of postoperative fluoroscopy
shows no cement migration. In addition,
there is little cement leakage from
needle track (arrows). Patient had no
significant symptoms. 
A
B
CDCase 2
A 38-year-old woman was admitted to the hospital due
to severe low back pain as a result of a sacral metastatic
tumor associated with lung cancer (determined by a biopsy
before the procedure). Both lumbo-sacral CT and MRI
examinations showed an osteolytic change at the S1 level.
The patient’s image results revealed a destroyed cortex
margin and was deemed not to be suitable for sacroplasty
(Fig. 2A, B). However, the patient and her family strongly
urged in favor of the operation, whatever the outcome.
After obtaining informed consent, sacroplasty was
performed under fluoroscopic guidance according to the
technique described in Case 1. The procedure was well
tolerated without significant complication except for the
cement deposition in the needle track (Fig. 2C, D).
Unfortunately, no CT images were available to display the
distribution of PMMA to determine whether or not it
leaked into neural foramina. However, the patient experi-
enced considerable pain relief with no complaints of nerve
root compression following the procedure. A 20 week
post-operative follow-up over the telephone found that the
patient experienced little pain and continued to walk
independently. 
DISCUSSION
Spinal metasatic tumors usually cause severe pain and
immobility, requiring a high dose of opiates for pain relief
(4). Currently, there is no ideal therapy available for the
treatment of these lesions. Non-operative therapy for
painful spinal metastasis includes bed rest, bracing, analge-
sia, radiotherapy, and chemotherapy, but the shortcoming
of all these methods are that none can correct sacral
instability. Surgical correction results in prolonged postop-
erative recovery time, with a high mortality rate 19% to
48% (5, 6), which is not a good option in patients with
limited life expectancy.
Osteoplasty is an effective palliative treatment for
symptomatic spinal metastases, relieving pain and improv-
ing quality of life (7, 8). The author’s two sacroplasty cases
provided marked pain relief, improved daily living
activity, and no significant complications, except for
cement disposition in the needle track in the female
patient. 
The mechanism of pain relief in patients with metastatic
lesions treated by cement injection is currently not well
understood. Stabilization of the micro-fractures and the
analgesic effect of PMMA due to the thermal effect in itself
seemed to be the main factors for short-term pain relief.
Long-term pain relief will probably require volume
reduction and necrosis of the tumor (9, 10). 
Although the percutaneous sacroplasty technique is
similar to vertebroplasty, there are several technical
considerations to deal with which are not encountered
when performing a vertebroplasty. Notably, it was difficult
to locate the needle tip because the curved ventral cortical
margin of the sacrum was difficult to see. Another concern
was the risk of cement migration and the compression of
the sacral nerve roots and sacral spinal canal. 
Our two sacroplasties, performed entirely under fluoro-
scopic guidance, were successful; however, we recognize
that the exclusive use of fluoroscopic guidance is problem-
atic due to the difficulty in visualizing the sacral foramina.
The visualization indicates whether the needle has
adequately traversed the dorsal cortex and has not
breached the ventral cortex, while also determining the
distribution of PMMA. Although we did not encounter any
complications related to the needle puncture and cement
extravasation, this technique remains has potential risks.
The CT-guided approach gives better definition of the
spatial relationships within the treatment field, which aids
in preventing patient injury to the nearby vascular,
neurological, and visceral structures. The CT also can
provide more accurate imaging of complex fracture planes
as well as enabling a higher level of precision in targeting
the needle tip to the tumor. The relative limitation of CT-
guidance is the lack of real-time monitoring of cement
delivery and quick detection of stray cement extravasa-
tion.
A combination of the CT and fluoroscopic guidance may
be the best alternative at present, which has been accepted
by many authors (1, 3). Pommersheim et al. (2) suggest a
CT-fluoroscopy suite might be the ideal setting to allow for
both precise needle placement and real-time visualization
of cement delivery. 
In conclusion, sacroplasties may be performed under
fluoroscopic guidance only, although they are technically
demanding and involve an increased risk of injury. Our
success in performing the sacroplasties was attributed to
performing 837 vertebroplasties over a six year period.
We recommend that physicians have extensive experience
in performing vertebroplasties before attempting sacral
repair. 
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